Verdinexor

Generic Name: Verdinexor

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: C_₁₈H_₁₂F_₆N_₆O

CAS Number: 1392136-43-4

Unique Ingredient Identifier: 85Q03215IW

Background: Kpt 335 is under investigation in clinical trial NCT02431364 (Trial of Safety and Tolerability of Oral Verdinexor (Verdinexor) in Healthy Adults).

Associated Conditions: -

Associated Therapies: -

Clinical Trials

Trial of Safety and Tolerability of Oral Verdinexor (KPT-335) in Healthy Adults

Phase 1

Terminated

Conditions: Healthy

Interventions: Other: Placebo
Drug: Verdinexor

First Posted Date: 2015-05-01

Last Posted Date: 2023-01-20

Lead Sponsor: Karyopharm Therapeutics Inc

Target Recruit Count: 33

Registration Number: NCT02431364

Locations: 🇦🇺
Nucleus Network, Melbourne, Victoria, Australia

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy